The Morning Blunt

Volume 4|Issue 7 December 7, 2018

Surgeon General Says Schedule 1 Status Inhibits Research

Marijuana Moment  // 12.6.18

Thursday the US Surgeon General Jerome Adams voiced his concerns over marijuana’s Schedule 1 status. Adams says the status inhibits researchers from studying marijuana. Adams, who has previously stated his support for medical research on cannabis, made the comment at a Police Assisted Addiction Recovery Initiative conference in Massachusetts.

The Morning Blunt

Volume 4|Issue 6 December 6, 2018


The Environmental Impact of Marijuana Legalization 

The Guardian // 12.4.18  Scientists fear that the rapid legalization of marijuana will cause a blind eye to be turned to the environmental impacts of large-scale cultivation. Many pesticides are legal for use in production, and there is little to no regulation about disposal of contaminated water, meaning that is infiltrating the clean water supply for North America. Scientists are urging legislature to consider the impact that the marijuana industry has on water quality and the long-term effects of releasing pesticides into the volatile ecosystem.

The Morning Blunt

Volume 4|Issue 5 December 5, 2018


Bay Area Cannabis Researchers Claim Breakthrough Against Chronic Disease 

The Mercury News // 12.4.18  Dr Michael Moskowitz, President of the Cannabis Research Consortium of Marin (County), studies THCV (tetrahyrdocannabivarin), one of the rarest and most medically beneficial cannabinoids found in cannabis plants. THCV acts as an anti-inflammatory, anti-epileptic, anti-nausea, and anti-anxiety agent, with little to no harmful side effects. Moskowitz’s research aims to promote and commercialize the medicinal benefits of THCV, similar to the rising popularity of CBD.

Sampling Cannabis in Products and Matrices  

Science of Cannabis Online Symposium 2018  Seth Wong, President, TEQ Analytical, gave a lecture at The Science of Cannabis Online Symposium 2018. Wong goes into the detailed sampling requirements for the cannabis industry in Colorado and covers sampling procedure and regulation in cultivation and processing facilities. The report discusses at length the troubles with sample heterogeneity and what better practices can do to overcome these challenges.

Columbia Care Launches Study to Prove Medical Benefits of Cannabis 

Cannabis Business Times // 12.3.18  Columbia Care has teamed up with Columbia University to research and compare the active ingredients in cannabis products with the active ingredients in opioids in the only nationally funded study in the country. This project will expand on a former study by Columbia Care which proved that patients being treated with opioids reportedly decreased or stopped opioid use while using medicinal cannabis. CEO of Columbia Care wants to change the way scientists and policy makers view medical cannabis.

The Cannabis Industry Is Scaling with The Help Of New Technologies  

Forbes // 12.3.18  Blockchain technology tries to offer solutions to the cash-centric nature of the cannabis industry and the lack of supply chain tracking and regulation. Over the next 3-4 years, crypto-currency and plant to product tracking using blockchain will be tested out in the industry.

The Morning Blunt

Volume 4|Issue 4 December 4, 2018


One-Third of Patients Using CBD for Epilepsy Develop Tolerance

Shimrit Uliel-Sibony, MD, of Tel Aviv Sourasky Medical Center’s Dana Children’s Hospital, reported CBD tolerance developed in 32.6% of patients with treatment-resistant seizures who used cannabis oil for an average of 19.8 months.

Minnesota Adds Alzheimer’s to Medical Marijuana List

Minnesota’s Department of Health announced Monday that Alzheimer’s will be added to its cannabis program. Although research on the effects of cannabis on Alzheimer’s is limited, some studies have found marijuana inhibits the formation of tau proteins that accelerate dementia and memory loss associated with the disease.

The Morning Blunt

Volume 4|Issue 3 December 3, 2018


Vaping Cannabis More Powerful Than Smoking

The Johns Hopkins Behavioral Pharmacology Research Unit in Baltimore conducted a study on 17 participants who were asked to smoke or vape either 0mg, 10mg, or 25mg of THC. Over six sessions lasting 8.5 hours, researchers concluded that cannabis that was vaped caused more negative drug effects and cognitive impairment than smoking.

Canopy & Tilray Conduct Cannabis Studies on Elderly

Canopy Growth and the Ontario Long Term Care Association have teamed up to begin working on a six month pilot program to track and monitor the effects of medicinal cannabis across 500 seniors. Similarly, Tilray is launching a sleep study today, December 3. Tilray hopes to examine the effects of medical marijuana on sleep, pain perception, and quality of life in patients over 50 years of age.

Cannabis & Nanotechnologies Don’t Mix

As companies work to create cannabinoid beverages, several are considering using nanotechnologies to mix fat-soluble cannabinoids into beverages. However, there is a growing concern that using nanotechnologies to mix cannabinoids into beverages could be harmful to consumer health. Trait Biosciences Inc says they have created pure, water-soluble cannabinoids.

Wastewater Suggests Halifax Consumes the Most Cannabis in Canada

A recent study from Statistics Canada, using technology called wastewater-based epidemiology, analyzed wastewater from 15 treatment plants across Canada. The results suggest Halifax had the highest consumption per capita at 1,310 micrograms per person per week.

The Morning Blunt

Volume 3|Issue 30 November 30, 2018


A Primer on Cannabis Vape Cartridges

The three most common types of cannabis extract you will find in vape form are derived from distillation, CO2 extraction, or live resin extraction. For more information take a look at the article for differences in extraction type, terpene levels, THC levels, and how these extracts are produced.

Cannabis Users Have Psychotic Like Experiences Via Person-Specific Pathways

According to a study published by the JAMA Psychiatry cannabis use is associated with psychotic-like experiences via person-specific pathways that are independent of genetic predisposition or environmental factors.

Humulene: A Terpene of Interest?

Humulene, an effective anti-inflammatory, antibacterial, and appetite suppressant, is a common terpene found in cannabis and hops. Humulene is present in Balsam fir oil and is claimed to fight tumors due to its ability to produce Reactive Oxygen Species.

The Morning Blunt

Volume 3|Issue 29 November 29, 2018


Redfund Backed Biolog Partners with Cannabis Strategic Ventures to Develop Water Soluble Cannabis Technologies

Biolog Inc., backed by Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF), and Cannabis Strategic Ventures Inc. (OTC: NUGS) announced a partnership to develop water soluble cannabis technologies for the food and beverage and consumer industries.

The Morning Blunt

Volume 3|Issue 27 November 27, 2018


Ultrasonic Extraction

Extractors are now using ultrasonic vibrations to create more potent cannabis concentrates at a faster rate with a more complete palate of the plant’s compound profile. Through a process called sonication, ultrasonic extraction can yield 15% of a bud by weight in full spectrum concentrates.

More Research Needed…

While there are many testimonials and anecdotal reports claiming the health benefits of CBD, Evidence so far is underwhelming that CBD is the medical cure-all many claim it to be. Medical researcher Jason Dyck agrees that the most promising research will be analyzing how combinations of broad-spectrum cannabinoids and terpenes work together. Dyck is only interested in extracting broad spectrum cannabinoids, arguing that the combination of compounds has more benefit than CBD and THC isolate.

Canada’s First Academic Cannabis Researcher

In January Yang Qu, one of Canada’s foremost anti-cancer drug researchers, will begin focusing solely on cannabis research at the University of New Brunswick. Qu hopes to develop synthetic cannabinoids, which will result in higher yields and purer compounds.

The Morning Blunt

Volume 3|Issue 26 November 26, 2018

“The best way to predict the future is to create it.”

–Peter Drucker


Researchers Identify Genes for Cannabinoids Though the cannabis genome was sequenced in 2011, teams of US and Canadian researchers have finally located the genes responsible for THC and CBD levels. The genes were found amid DNA deposited in the plant’s genome by viruses during its evolution, leaving researchers to conclude that these genes were possibly evolutionarily created as a result of viral exposure. Advanced Extraction Systems Looking to Expand With the Industry Advanced Extraction Systems Inc., a firm focused on manufacturing and selling oil extraction equipment to the cannabis and hemp industry, is expanding to meet the needs of the growing industry. Advanced Extraction Systems is designing a two-by-1,000 liter system that is expandable to four-by-1,000 liters and can process 3,500 kilograms of cannabis per day. The Endocannabinoid System & Appetite The endocannabinoid system is one of many biological methods the body employs to trigger hunger or fullness. The endocannabinoid system interacts with marijuana and often gives the consumer the munchies. According to Lab Roots’ Amy Loriaux if a substance, like marijuana, can affect physiological systems like appetite, it points to a system that regulates appetite. Take a closer look at how cannabis impacts appetite and the endocannabinoid system. Conducting Research Under Federal Regulation The National Center for Complementary and Integrative Health, at the National Institutes of Health, is sponsoring a workshop on Dec. 8, 2018 to discuss the issues related to conducting research on cannabinoids under the current regulatory framework. The event will bring together researchers, government officials, and industry representatives to foster collaborations for future research opportunities.

The Morning Blunt

Volume 3| Issue 16 November 16, 2018

“Don’t let yesterday take up too much of today.

–Will Rogers


Beleave Develops Water Soluble Cannabis-Infused Powder & Sugar

Beleave Inc. (CSE: BE) (OTCQX: BLEVF) announced that it has developed water soluble cannabis-infused powder and sugar products to prepare for the adult recreational cannabis-infused food and beverage market next year.